Biotherapies’ mode of action and pharmacology in inflammatory and autoimmune diseases : tocilizumab and polymyalgia rheumatica. Effets pharmacodynamiques et pharmacocinétiques des biothérapies dans les maladies auto-immunes et inflammatoires
Polymyalgia rheumatica (PMR) is an inflammatory rheumatism affecting people over50 years of age. Polymyalgia rheumatica is sometimes associated with giant cell arteritis.Strong inflammation and a quick response to glucocorticoids ...
Against the dryness—an innovative 3D acini model to test new drugs in primary Sjögren’s syndrome
